Multiple antibiotic resistance as a risk factor for mortality and prolonged hospital stay: A cohort study among neonatal intensive care patients with hospital-acquired infections caused by gram-negative bacteria in Vietnam

Abstract

Background Antibiotic resistance (ABR) is an increasing burden for global health. The prevalence of ABR in Southeast Asia is among the highest worldwide, especially in relation to hospital-acquired infections (HAI) in intensive care units (ICU). However, little is known about morbidity and mortality attributable to ABR in neonates. Aim This study aimed to assess mortality and the length of hospitalization attributable to ABR in gram-negative bacteria (GNB) causing HAI in a Vietnamese neonatal ICU (NICU). Methods We conducted a prospective cohort study (n = 296) in a NICU in Hanoi, Vietnam, from March 2016 to October 2017. Patients isolated with HAI caused by GNB were included. The exposure was resistance to multiple antibiotic classes, the two outcomes were mortality and length of hospital stay (LOS). Data were analysed using two regression models, controlling for confounders and effect modifiers such as co-morbidities, time at risk, severity of illness, sex, age, and birthweight. Results The overall case fatality rate was 44.3% and the 30 days mortality rate after infection was 31.8%. For every additional resistance to an antibiotic class, the odds of a fatal outcome increased by 27% and LOS increased by 2.1 days. These results were statistically significant ( p < 0.05). Conclusion ABR was identified as a significant risk factor for adverse outcomes in neonates with HAI. These findings are generally in line with previous research in children and adults. However, heterogeneous study designs, the neglect of important confounders and varying definitions of ABR impair the validity, reliability, and comparability of results.

<p>Three Years of Evaluation to Determine Reduction of Antibiotic Resistance in Gram-Negative Bacteria by the Saudi National Action Plan</p>

“…The reductions in ESBL and MDR had fortunate consequences such as raising the rate of treatment success and decreasing rates of morbidity and mortality. 6,[32][33][34] While we found resistance to all antibiotics to generally reduce over time, SXT was an exception. This finding is probably linked to patterns in the use of antimicrobial therapy and may reflect selective reporting of resistance testing.…”

Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial

“…Clostridioides difficile. 2,3 Prudent use of antimicrobials integrated with antibiotic stewardship programs is vital in overcoming emergence of antimicrobial resistance.…”

<p>Bacteriophages, a New Therapeutic Solution for Inhibiting Multidrug-Resistant Bacteria Causing Wound Infection: Lesson from Animal Models and Clinical Trials</p>

“…[27][28][29][30] Reports have shown that infections with high antibiotic resistance can result in increased hospitalization time, delay in antimicrobial therapy, use of high toxic antibiotics, increase costs, and many other problems for patients. 21,31 Because of the widespread resistance to antibiotics and the decline in the production of new antimicrobial agents, phage therapy as a novel, safe and attractive strategy for researchers. 21 Therefore, phage therapy has become more popular after the occurrence of antibiotic resistance, and now many institutes and researchers are looking for new ways to improve phage therapy.…”